Better Therapeutics, Inc. (BTTX) Operating Income (Loss) USD 2020 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Better Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
  • Better Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$5.34 M, a 51.4% increase year-over-year.
  • Better Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$29.6 M, a 29.6% increase year-over-year.
  • Better Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$38.3 M, a 25.2% decline from 2021.
  • Better Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$30.6 M, a 383% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$29.6 M -$5.34 M +$5.66 M +51.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$35.3 M -$7.03 M +$2.57 M +26.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 -$37.8 M -$8.93 M +$420 K +4.49% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$38.3 M -$8.32 M +$3.78 M +31.2% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-30
Q3 2022 -$42 M -$11 M -$2 M -22.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$40 M -$9.6 M -$3.13 M -48.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$36.9 M -$9.35 M -$6.36 M -213% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$30.6 M -$12.1 M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$9 M -$8.99 M -899400% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$6.47 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$2.99 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q3 2020 -$1 K* Jul 31, 2020 Sep 30, 2020 10-Q 2021-11-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.